A Phase 2 Open Label Study to Assess the Efficacy and Safety of Etanercept (Enbrel)for the Treatment of Discoid Lupus Erythematosus.
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Etanercept (Primary)
- Indications Discoid lupus erythematosus
- Focus Therapeutic Use
- Acronyms DISCLUP2008
- 25 May 2010 Planned end date changed from 1 Oct 2009 to 1 Apr 2011 as reported by ClinicalTrials.gov.
- 02 Dec 2008 New trial record.